insights_auto
Why is 4AB up 2.25%?
Dive Deeperchevron_right
4AB:ETR
AbbVie Common Stock
€268.10
arrow_upward
+2.25%(+5.90) 1D
Nov 12, 5:35:30 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€267.40
High
€268.70
Low
€267.00
Mkt. cap
520.47B
Avg. vol.
722.00
Volume
198.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
Open
€267.40
High
€268.70
Low
€267.00
Mkt. cap
520.47B
Avg. vol.
722.00
Volume
198.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
NewsBreak: Local News & Alerts
·
12 hours ago
3 Pharmaceutical Stocks That Offer Safety and Growth
Yahoo Finance
·
13 hours ago
AbbVie Deal Altering The Investment Case For Nxera Pharma Stock (TSE:4565)?
Trefis
·
14 hours ago
Could AbbVie Stock Survive A Skyrizi And Rinvoq Slowdown?
The Globe and Mail
·
23 hours ago
ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com